Boehringer Ingelheim organizes the workshop "A decade of comprehensive protection of Cardiovascular - Kidney - Metabolism"

The biopharmaceutical group Boehringer Ingelheim recently coordinated with the Vietnam Cardiology Association to organize the workshop "A decade of comprehensive protection of the Cardiovascular - Kidney - Metabolism" to celebrate the 10th anniversary of Empagliflozin being officially introduced into the treatment process for patients around the world.

Báo Sài Gòn Giải phóng•12/04/2025

The workshop brought together leading experts in the field of Cardiovascular - Renal - Metabolism domestically and internationally, along with more than 800 medical staff participating directly and online, to discuss advanced treatment trends, especially emphasizing the importance of early intervention and comprehensive management of Cardiovascular - Renal - Metabolic diseases.

Not only providing an opportunity to update specialized knowledge, the conference also marks an important step forward in the journey of treatment innovation not only in Vietnam but also in other countries around the world. With the latest clinical data and effective treatment solutions, it opens up new prospects in controlling Cardiovascular - Renal - Metabolic diseases, contributing to improving the quality of life for patients worldwide. Experts at the conference also emphasized the essential role of coordination between many medical specialties and early intervention to effectively manage Cardiovascular - Renal - Metabolic diseases.

THAI HOANG

Source: https://www.sggp.org.vn/boehringer-ingelheim-to-chuc-hoi-thao-mot-thap-ky-bao-ve-toan-dien-tim-mach-than-chuyen-hoa-post790283.html